Eli Lilly quells fears that its GLP-1 pill debut is off to a rocky start

Early prescription data for Foundayo showed the pill was having a lackluster rollout compared to its competitor.

Source: Sherwood News.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *